volume 99, issue 4, P575-580 1997
DOI: 10.1542/peds.99.4.575
View full text
J. C. King Jr, P. E. Vink, J. J. Farley, M. Smilie, M. Parks, R. Lichenstein

Abstract: Three doses of PCV seem safe and immunogenic in both HIV- and non-HIV-infected children younger than 2 years. This type of vaccine should result in a marked reduction in systemic pneumococcal disease in both HIV- and non-HIV-infected children. Given the high incidence of invasive pneumococcal disease in HIV-infected children, this vaccine may markedly improve the quality of life for this unfortunate group of children.